DK0977577T3 - Præparater til behandling af ARDS eller IRDS indeholdende 3-(cyclopropylmethoxy)-N-(3,5-dichlor-4-pyridinyl)-4-(difluormethoxy)benzamid og lungesurfaktant - Google Patents

Præparater til behandling af ARDS eller IRDS indeholdende 3-(cyclopropylmethoxy)-N-(3,5-dichlor-4-pyridinyl)-4-(difluormethoxy)benzamid og lungesurfaktant

Info

Publication number
DK0977577T3
DK0977577T3 DK98910670T DK98910670T DK0977577T3 DK 0977577 T3 DK0977577 T3 DK 0977577T3 DK 98910670 T DK98910670 T DK 98910670T DK 98910670 T DK98910670 T DK 98910670T DK 0977577 T3 DK0977577 T3 DK 0977577T3
Authority
DK
Denmark
Prior art keywords
irds
cyclopropylmethoxy
ards
treatment
difluoromethoxy
Prior art date
Application number
DK98910670T
Other languages
English (en)
Inventor
Ulrich Kilian
Rolf Beume
Uwe Krueger
Dietrich Haefner
Klaus Eistetter
Paul-Georg Germann
Hermann Amschler
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19705924A external-priority patent/DE19705924A1/de
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK0977577T3 publication Critical patent/DK0977577T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
DK98910670T 1997-02-17 1998-02-14 Præparater til behandling af ARDS eller IRDS indeholdende 3-(cyclopropylmethoxy)-N-(3,5-dichlor-4-pyridinyl)-4-(difluormethoxy)benzamid og lungesurfaktant DK0977577T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19705924A DE19705924A1 (de) 1997-02-17 1997-02-17 Neue Zusammensetzungen
EP97102639 1997-02-19

Publications (1)

Publication Number Publication Date
DK0977577T3 true DK0977577T3 (da) 2006-12-18

Family

ID=26033977

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98910670T DK0977577T3 (da) 1997-02-17 1998-02-14 Præparater til behandling af ARDS eller IRDS indeholdende 3-(cyclopropylmethoxy)-N-(3,5-dichlor-4-pyridinyl)-4-(difluormethoxy)benzamid og lungesurfaktant

Country Status (26)

Country Link
US (2) US6436970B1 (da)
EP (1) EP0977577B1 (da)
JP (1) JP4763104B2 (da)
KR (1) KR100640025B1 (da)
CN (1) CN1123345C (da)
AT (1) ATE336254T1 (da)
AU (1) AU734122B2 (da)
BR (1) BR9807399B1 (da)
CA (1) CA2276429C (da)
CZ (1) CZ293871B6 (da)
DE (1) DE69835594T2 (da)
DK (1) DK0977577T3 (da)
EA (1) EA001758B1 (da)
EE (1) EE04094B1 (da)
ES (1) ES2271990T3 (da)
HK (1) HK1026145A1 (da)
HU (1) HU227520B1 (da)
IL (1) IL130658A (da)
NO (1) NO323594B1 (da)
NZ (1) NZ336569A (da)
PL (1) PL190775B1 (da)
PT (1) PT977577E (da)
SI (1) SI0977577T1 (da)
TR (1) TR199901772T2 (da)
UA (1) UA50808C2 (da)
WO (1) WO1998035683A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2276429C (en) * 1997-02-17 2007-06-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant
EP1216052A1 (en) * 1999-09-16 2002-06-26 Byk Gulden Lomberg Chemische Fabrik GmbH Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
JP2003534328A (ja) 2000-05-25 2003-11-18 メルク フロスト カナダ アンド カンパニー フルオロアルコキシ置換ベンズアミドジクロロピリジニルｎ−オキシドｐｄｅ４阻害剤
ATE303384T1 (de) 2001-05-24 2005-09-15 Merck Frosst Canada Inc 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
US20030099601A1 (en) * 2001-11-27 2003-05-29 Gordon Marc S. Inhalation lung surfactant therapy
US6998384B2 (en) * 2001-12-12 2006-02-14 The Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
US20030170223A1 (en) * 2002-02-01 2003-09-11 Board Of Trustees Of Michigan State University Pulmonary vasodilator surfactant compositions and method of use
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US6822114B1 (en) 2002-10-08 2004-11-23 Albemarle Corporation Process for production of fluoroalkoxy-substituted benzamides and their intermediates
CA2506956C (en) * 2002-11-27 2012-10-02 Altana Pharma Ag Synergistic combination comprising roflumilast and (r,r)-formoterol
WO2004047829A1 (en) * 2002-11-27 2004-06-10 Altana Pharma Ag New synergistic combination comprising roflumilast and formoterol
CA2503290C (en) 2003-03-10 2012-12-04 Altana Pharma Ag Novel process for the preparation of roflumilast
CA2529007C (en) 2003-06-16 2012-03-27 Altana Pharma Ag Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
CA2575513C (en) * 2004-08-06 2014-09-16 Altana Pharma Ag Composition comprising a pulmonary surfactant and a tnf-derived peptide
EP1861074B1 (en) * 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
AR064307A1 (es) * 2006-12-13 2009-03-25 Gilead Sciences Inc Monofosfatos utiles para el tratamiento de la inflamacion pulmonar y broncoconstriccion, formulaciones aerosolicas que los contienen, y metodo de preparacion.
WO2009055788A1 (en) * 2007-10-26 2009-04-30 Aeris Therapeutics, Inc. Pneumoreductive therapy and compositions useful therein
WO2015016761A2 (en) * 2013-08-01 2015-02-05 Isletone Ab Mscs in the treatment of inflammatory pulmonary diseases
CN104800214A (zh) * 2014-01-27 2015-07-29 成都英诺新科技有限公司 一种罗氟司特吸入气雾剂复方及制备方法
RU2728821C1 (ru) * 2020-05-13 2020-07-31 Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства" (ФГБУН НЦБМТ ФМБА России) Способ лечения острого респираторного дистресс-синдрома даларгином и легочным сурфактантом

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223040A (en) * 1974-11-26 1980-09-16 Carroll John M Lauric acid for the prevention and treatment of mycobacterial diseases
JPS5795920A (en) * 1980-12-04 1982-06-15 Teijin Ltd Remedy for respiratory disease
JPS5845299A (ja) * 1981-09-10 1983-03-16 東京田辺製薬株式会社 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤
GR82072B (da) * 1983-05-11 1984-12-13 Byk Gulden Lomberg Chem Fab
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
US5712298A (en) * 1993-07-02 1998-01-27 Byk Gulden Lomberg Chemische Fabrik Gmbh Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
US5856196A (en) * 1993-10-25 1999-01-05 Beth Israel Hospital Processes for quantitating phosphoglycerides in a lipid mixture and diagnostic uses therefor
GB9401460D0 (en) 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
DE4434629C1 (de) * 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
US5531219A (en) * 1994-11-04 1996-07-02 Alliance Pharmaceutical Corp. Use of liquid fluorocarbons to facilitate pulmonary drug delivery
US5698537A (en) * 1996-06-18 1997-12-16 Clarion Pharmaceuticals Inc. Method of lowering the viscosity of mucus
CA2276429C (en) * 1997-02-17 2007-06-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant
US6180142B1 (en) * 1998-08-21 2001-01-30 The Regents Of The University Of California Reduction of surfactant inactivation in pulmonary surfactant therapy
WO2001000338A1 (en) * 1999-06-29 2001-01-04 L-Tech Corporation Chemical film cleaning and drying

Also Published As

Publication number Publication date
AU6497398A (en) 1998-09-08
TR199901772T2 (da) 1999-09-21
HUP0001043A3 (en) 2002-12-28
EA199900645A1 (ru) 2000-04-24
DE69835594T2 (de) 2007-08-16
US6436970B1 (en) 2002-08-20
DE69835594D1 (de) 2006-09-28
US20020132835A1 (en) 2002-09-19
BR9807399A (pt) 2000-03-14
IL130658A0 (en) 2000-06-01
EE9900279A (et) 2000-02-15
JP2001512452A (ja) 2001-08-21
JP4763104B2 (ja) 2011-08-31
PL190775B1 (pl) 2006-01-31
CN1248169A (zh) 2000-03-22
US6998410B2 (en) 2006-02-14
NO323594B1 (no) 2007-06-11
PL335134A1 (en) 2000-04-10
SI0977577T1 (sl) 2007-02-28
CA2276429C (en) 2007-06-19
KR20000071112A (ko) 2000-11-25
NO993875D0 (no) 1999-08-11
EP0977577A1 (en) 2000-02-09
WO1998035683A1 (en) 1998-08-20
PT977577E (pt) 2007-02-28
IL130658A (en) 2004-07-25
EA001758B1 (ru) 2001-08-27
HUP0001043A2 (hu) 2000-09-28
CA2276429A1 (en) 1998-08-20
HU227520B1 (hu) 2011-07-28
CN1123345C (zh) 2003-10-08
HK1026145A1 (en) 2000-12-08
CZ291499A3 (cs) 2000-02-16
EP0977577B1 (en) 2006-08-16
AU734122B2 (en) 2001-06-07
ES2271990T3 (es) 2007-04-16
KR100640025B1 (ko) 2006-10-31
NZ336569A (en) 2001-04-27
ATE336254T1 (de) 2006-09-15
BR9807399B1 (pt) 2011-04-19
UA50808C2 (uk) 2002-11-15
NO993875L (no) 1999-08-11
EE04094B1 (et) 2003-08-15
CZ293871B6 (cs) 2004-08-18

Similar Documents

Publication Publication Date Title
DK0977577T3 (da) Præparater til behandling af ARDS eller IRDS indeholdende 3-(cyclopropylmethoxy)-N-(3,5-dichlor-4-pyridinyl)-4-(difluormethoxy)benzamid og lungesurfaktant
NO20011842D0 (no) Stabile, konsentrerte insulinpreparater for pulmonal avlevering
NO964548D0 (no) Substituerte sulfonamider som selektive 3 agonister for behandling av diabetes og fedme
DE68927025D1 (de) HIV-2-Virusvarianten
DK0705099T3 (da) Anvendelse af modafinil til behandling af søvnapnø og åndedrætslidelser af central oprindelse
DK1363608T3 (da) Formuleringer omfattende ibuprofen og diphenhydramin og deres anvendelse til behandling af sovnforstyrrelser
DK0806942T3 (da) Stivelsesacetat-præparat med modificerbare egenskaber, fremgangsmåde til fremstilling og anvendelse deraf
DE59308848D1 (de) Anwendung von urodilatin bei lungen- und bronchialerkrankungen
ID28119A (id) Pati yang dimodifikasi stabil-garam
ATE231522T1 (de) Fragmente eines oberflächenaktiven lungenproteins
NO894532D0 (no) Titandioksyd, fremgangsmaate for dets fremstilling og anvendelse derav.
ATE121779T1 (de) Nichtzurückschlagende rns-viren.
DE69523055T2 (de) T-zellen stimulierendes protein von pestivirus
DK0614657T3 (da) Middel til permanentbølgning af menneskehår
DK210081A (da) 1-(3,5-bistrifluormethylphenyl)-3-(4-tert. butylpiperidino)-prop-1-yn eller syreadditionssalte deraf dets fremstilling og anvendelse som rodenticid
NO911465D0 (no) Fremgangsmaate for fremstilling av 4-(3-(4-oksotiazoldinyl))-butynylaminer og deres anvendelse som medikamenter.
DK179176A (da) 4-amino-5-thion-1,2,4-triaziner (4,5-h), deres fremstilling og anvendelse som herbicider
ATE356806T1 (de) Salze von amlodipin-mesylat
DK203784D0 (da) 1-(4-(4-(fluoralkylmethylthio-eller-sulfinyl-eller-sulfonyl-)-phenoxy)phenyl)-1,3,5-triazin-2,4,6(1h,3h,5h)trioner,fremgangsmaade til fremstilling deraf og deres anvendelse som coccidiosemidler
NO20000262D0 (no) Plasmider, deres konstruksjon og deres anvendelse i fremstilling av interleukin-4 og interleukin-4-muteiner
DK1149901T3 (da) Mutanter af pestivirus og vacciner indeholdende disse
NO901892D0 (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.
DK340489D0 (da) Fremstilling af svaekkede rna virale stammer og vacciner omfattende disse
DK581281A (da) N-sulfenylerede allophanater fremgangsmaade til deres fremstilling og deres anvendelse som fungicider
NO930858D0 (no) Stoff som kan stoppe bloedning, f.eks. ved kirurgiske og dentale inngrep